RUNX2 and osteosarcoma: In addition, it has been found that there exists a positive correlation between RUNX2 gene amplification and poor chemo-response in osteosarcoma patients.32 Unfortunately, the precise molecular mechanism(s) how RUNX2 could contribute to the development and progression of the above-mentioned cancers remains elusive.